The tweet was deleted by the author.
But we saved everything 🙂.
Jonah Lupton highlights that many viable kidneys are discarded due to ischemia, a condition that affects organ preservation.
He states that TMDX has the potential to address this problem by improving the viability of kidneys for transplantation.